HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Pre-IPO BeiGene - Would the IPO on the STAR Market Be the Last Hurrah?

Pre-IPO SciClone Pharmaceuticals - Here Are the Strength and the Concerns

Bloomage Biotechnology (688363.CH) - Accelerated Growth with the Approval of New Regulation

Industry Report - Insights on China Vaccine Industry

Hygeia Healthcare Group (6078 HK) - Good Business Model with Large Market Potential

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

Equity Bottom-Up

Sihuan Pharmaceutical Hldgs / Equity Bottom-Up

<a href="https://www.smartkarma.com/entities/sihuan-pharmaceutical-hldgs" target="_blank" data-smartkarma-citation="entities:33:1" rel="noopener">Sihuan Pharmaceutical Hldgs (460 HK)</a> is one of the largest suppliers of cardio-cerebral vascular (“CCV”) prescription drugs in China. The Company is currently conducting more than 110 pharmaceutical research projects and over 300 patents on innovative drugs have been granted. The current pipeline covers key therapeutic areas including diabetes, oncology, anti-infectives, non-alcoholic steatohepatitis and so on. From January 19th to January 29th, Sihuan's share price rose about 110% in ten days, and the highest price ever reached HK$2.32. The question is, what happened to this Company that cause its share price to increase sharply?

Sihuan Pharmaceutical Hldgs (460 HK) is one of the largest suppliers of cardio-cerebral vascular (“CCV”) prescription drugs in China. The Company is currently conducting more than 110 pharmaceutical research projects and over 300 patents on innovative drugs have been granted. The current pipeline covers key therapeutic areas including diabetes, oncology, anti-infectives, non-alcoholic steatohepatitis and so on. From January 19th to January 29th, Sihuan's share price rose about 110% in ten days, and the highest price ever reached HK$2.32. The question is, what happened to this Company that cause its share price to increase sharply?

Sihuan Pharmaceutical (460 HK) - The Logic Behind the Rally of the Stock Price